OneSpaWorld posted record Q2 revenue and adjusted earnings, raised full-year guidance, and retains an analyst Buy rating, though it remains heavily dependent on the cruise industry.
PTC Therapeutics (NASDAQ:PTCT) plans to acquire the ST-920 Fabry disease gene therapy asset through a competitive bankruptcy auction, positioning the company to add a potential one-time treatment to its rare disease portfolio while using its existing global commercial and regulatory infrastructure.
Two quantum leaders are pursuing very different paths to commercial success. See which strategy may offer investors the stronger balance of upside, resilience, and long-term potential.
The Best Customers Are Already Searching for YouNot all website visitors translate into customers. Some shoplift, some look around, and others are ready to
Meta Platforms and Tesla show improving RSI readings after recent selloffs, with both Magnificent Seven stocks facing earnings volatility but analysts still forecasting double-digit upside ahead.
People Incorporated Common Stock (NASDAQ:PPLI) is focusing its capital allocation on its MGM minority stake and its People media business while seeking new homes for several non-core assets, Chief Financial Officer Tim Quinn said during a fireside chat.
Quinn said the former IAC has identified MGM
With their reliable business models, consistent dividend payouts, and disciplined capital investment strategies, these two dividend stocks are well suited for conservative income-focused investors seeking stable, long-term returns.
The space economy needs far more than rockets. Discover which hidden infrastructure providers could benefit, where their strongest advantages lie, and what could derail the opportunity.
